Basic Stats
| LEI | 549300D3FV73JB135D45 |
| CIK | 1074828 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Know Labs, Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| September 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2025 USBC, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction (Commission (I.R.S. Employer of incorporat |
|
| September 5, 2025 |
Up to $14,500,000 Common Stock As Filed Pursuant to Rule 424(b)(5) Registration No. 333-276246 PROSPECTUS SUPPLEMENT (To Prospectus dated January 11, 2024 and Prospectus Supplement dated December 31, 2024) Up to $14,500,000 Common Stock This prospectus supplement amends and supplements the information in the prospectus, dated January 11, 2024, filed as a part of our registration statement on Form S-3 (File No. 333-276246), as s |
|
| August 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| August 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37479 KNOW LABS, INC. (Ex |
|
| August 15, 2025 |
USBC Announces Completion of Corporate Name and Ticker Change Following Strategic Acquisition EXHIBIT 99.1 USBC Announces Completion of Corporate Name and Ticker Change Following Strategic Acquisition RENO, NV (Globe Newswire), August 15, 2025, USBC, Inc. (NYSE American: USBC) (“USBC” or the “Company”) announced today that it has changed its name from Know Labs, Inc. to USBC, Inc. The Company’s common stock will now trade on the NYSE American under the new ticker symbol “USBC,” effective a |
|
| August 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2025 USBC, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| August 15, 2025 |
USBC, INC. INDEMNIFICATION AGREEMENT EXHIBIT 10.1 USBC, INC. INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is entered into as of [●], 2025 by and between USBC, Inc., a Nevada corporation (the “Company”), and the undersigned director, officer, employee, or agent of the Company (“Indemnitee”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in Section 11. WHEREAS |
|
| August 7, 2025 |
RESTRICTED AND UNRESTRICTED STOCK AWARD NOTICE USBC, INC. 2021 EQUITY INCENTIVE PLAN EXHIBIT 10.8 RESTRICTED AND UNRESTRICTED STOCK AWARD NOTICE USBC, INC. 2021 EQUITY INCENTIVE PLAN USBC, Inc. (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), has granted to Participant Restricted Stock and an (unrestricted) Stock Award (collectively, the “Award”). This Award is subject to all of the terms and conditions set forth in this Restricted and Unrestricted Stock A |
|
| August 7, 2025 |
NONQUALIFIED STOCK OPTION GRANT AGREEMENT USBC, INC. EXHIBIT 10.7 NONQUALIFIED STOCK OPTION GRANT AGREEMENT USBC, INC. This Nonqualified Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between USBC, Inc. (formerly, Know Labs, Inc.), a Nevada corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”). WHEREA |
|
| August 7, 2025 |
CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION EXHIBIT 3.1 CERTIFICATE OF AMENDMENT OF ARTICLES OF INCORPORATION KNOW LABS, INC. a corporation organized and existing under the laws of the State of Nevada (the “Corporation”), hereby certifies as follows: 1. Name of Corporation. The name of the corporation immediately prior to filing this Certificate of Amendment is Know Labs, Inc., and the Corporation’s Nevada Business Identification Number is |
|
| August 7, 2025 |
Risks Related to Ownership of our Common Stock EXHIBIT 99.2 Risks Related to Ownership of our Common Stock The Company is a “controlled company” within the meaning of the NYSE rules and, as a result, qualifies for exemptions from certain corporate governance requirements. The stockholders of the Company do not have the same protections afforded to stockholders of companies that are subject to such requirements. As of the Closing, Greg Kidd, ou |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 7, 2025 |
SEPARATION AND GENERAL RELEASE AGREEMENT EXHIBIT 10.2 August 6, 2025 Peter Conley Dear Peter: As discussed, enclosed please find a Separation and General Release Agreement (the “Agreement”) with respect to your separation of employment from Know Labs, Inc. (the “Company”), which will be upon the consummation of the transactions described in that certain Securities Purchase Agreement dated as of June 5, 2025, by and among the Company and |
|
| August 7, 2025 |
INCENTIVE STOCK OPTION GRANT AGREEMENT USBC, INC. EXHIBIT 10.6 INCENTIVE STOCK OPTION GRANT AGREEMENT USBC, INC. This Incentive Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between USBC, Inc. (formerly, Know Labs, Inc.), a Nevada corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”). WHEREAS, the |
|
| August 7, 2025 |
Digital Asset Management Agreement EXHIBIT 10.1 Digital Asset Management Agreement This Digital Asset Management Agreement (the “Agreement”) is entered into as of August 5, , 2025, (the “Effective Date”), by and between Hyrcanian Asset Management, LLC, a Puerto Rico limited liability company, acting as a digital asset manager, exempt from registration under the Investment Advisers Act of 1940 and the Commodity Exchange Act, with it |
|
| August 7, 2025 |
Greg Kidd & Know Labs Announce Closing of $125M Strategic Acquisition EXHIBIT 99.1 Greg Kidd & Know Labs Announce Closing of $125M Strategic Acquisition · Contribution of 1,000 Bitcoin to employ yield generation treasury strategy · Corporate name and ticker symbol will change to USBC · Greg Kidd to lead USBC as Chairman and CEO; USBC token sets new vision CRYSTAL BAY, NV and SEATTLE, WA -(BUSINESS WIRE) - Greg Kidd and Know Labs, Inc. (NYSE American: KNW (“Know Labs |
|
| August 7, 2025 |
USBC, Inc. Employment Agreement EXHIBIT 10.4 USBC, Inc. Employment Agreement This Employment Agreement (this “Agreement”), dated as of the 6th day of August, 2025, is made by and between USBC, Inc., a Nevada corporation (the “Company”), and Kitty Payne (“Executive”). The Company and Executive are together referred to herein as the “Parties” or individually referred to as a “Party”. WHEREAS, the Company desires to retain Executiv |
|
| August 7, 2025 |
USBC, INC. EMPLOYMENT AGREEMENT EXHIBIT 10.5 USBC, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”), dated as of the 6th day of August, 2025, is made by and between USBC, Inc., a Nevada corporation (the “Company”), and Kirk Chapman (“Executive”). The Company and Executive are together referred to herein as the “Parties” or individually referred to as a “Party”. WHEREAS, the Company desires to retain Executi |
|
| August 7, 2025 |
USBC, Inc. Employment Agreement EXHIBIT 10.3 USBC, Inc. Employment Agreement This Employment Agreement (this “Agreement”), dated as of the 6th day of August, 2025, is made by and between USBC, Inc., a Nevada corporation (the “Company”), and Gregory Kidd (“Executive”). The Company and Executive are together referred to herein as the “Parties” or individually referred to as a “Party”. WHEREAS, the Company desires to retain Executi |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File number 000-30262 KNOW LABS, INC. (Exact name of registrant as |
|
| August 5, 2025 |
As filed with the Securities and Exchange Commission on August 5, 2025 As filed with the Securities and Exchange Commission on August 5, 2025 Registration No. |
|
| August 5, 2025 |
2021 Know Labs, Inc. Equity Incentive Plan, as amended EXHIBIT 4.2 Know Labs, Inc. 2021 EQUITY INCENTIVE PLAN SECTION 1. PURPOSE The purpose of the Know labs, Inc. 2021 Equity Incentive Plan is to attract, retain and motivate employees, officers, directors, consultants, agents, advisors and independent contractors of the Company and its Related Companies by providing them the opportunity to acquire a proprietary interest in the Company and to align th |
|
| August 5, 2025 |
EXHIBIT 107 Calculation of Filing Fee Tables FORM S-8 ——— (Form Type) KNOW LABS, INC. |
|
| August 1, 2025 |
Amendment to Know Labs Inc. 2021 Equity Incentive Plan EXHIBIT 10.1 AMENDMENT TO THE KNOW LABS, INC. 2021 EQUITY INCENTIVE PLAN WHEREAS, Know Labs, Inc., a Nevada corporation (the “Company”) currently maintains and sponsors the Know Labs, Inc. 2021 Equity Incentive Plan, as amended (the “Plan”); and WHEREAS, Section 17.1 of the Plan provides that the Board of the Directors of the Company (“Board”) may amend the Plan from time to time; and WHEREAS, the |
|
| August 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 1, 2025 |
Certificate of Amendment to the Articles of Incorporation Amendment EXHIBIT 3.1 |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number |
|
| July 30, 2025 |
Promissory Note, dated July 28, 2025, by and between Know Labs, Inc. and Goldeneye 1995 LLC.* EXHIBIT 10.1 PROMISSORY NOTE July 28, 2025 (the “Effective Date”) $350,000.00 FOR VALUE RECEIVED, the undersigned Know Labs, Inc., a Nevada corporation (“Borrower”) hereby promises to pay to the order of Goldeneye 1995 LLC, a Nevada limited liability company (“Lender”) the aggregate principal sum of THREE HUNDRED AND FIFTY THOUSAND DOLLARS ($350,000.00), together with interest on the principal amo |
|
| July 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| July 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| July 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| July 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 6, 2025 |
EXHIBIT 10.2 FORM OF VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of [●], 2025, is by and among Goldeneye 1995 LLC, a Nevada limited liability company (“Buyer”), Know Labs Inc., a Nevada corporation (the “Company”), and the undersigned stockholder of the Company (each, a “Stockholder” and, collectively, the “Stockholders”). Capitalized terms used but |
|
| June 6, 2025 |
Amendment No. 1 to the Amended Employment Agreement of Ronald Erickson EXHIBIT 10.4 AMENDMENT NO. 1 TO THE AMENDED EMPLOYMENT AGREEMENT THIS AMENDMENT (this “Amendment”) is dated as of June 5, 2025 and amends that certain Amended Employment Agreement, dated as of March 22, 2018 (the “Agreement”), by and between Know Labs, Inc. (f/k/a Visualant Incorporated) (“Employer”) and Ronald Erickson (“Executive”) effective upon consummation of the Transaction (as defined below |
|
| June 6, 2025 |
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of June 5, 2025, by and among Know Labs, Inc., a Nevada corporation (the “Company”), and Goldeneye 1995 LLC, a Nevada limited liability company (the “Buyer” and together with the Company, the “Parties” and each a “Party”). WHEREAS, the Company and Buyer are executing and delivering this Agr |
|
| June 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 6, 2025 |
Amendment No. 1 to the Employment Agreement of Peter Conley EXHIBIT 10.5 AMENDMENT NO. 1 TO THE EMPLOYMENT AGREEMENT THIS AMENDMENT (this “Amendment”) is dated as of June 5, 2025 and amends that certain Employment Agreement, dated as of May 13, 2022 (the “Agreement”), by and between Know Labs, Inc. (“Employer”) and Peter Conley (“Executive”) effective upon consummation of the Transaction (as defined below) (the “Amendment Effective Date”). Capitalized term |
|
| June 6, 2025 |
Greg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury Strategy EXHIBIT 99.1 Greg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury Strategy SEATTLE, WA, June 6, 2025, Know Labs, Inc. (NYSE American: KNW (“Know Labs” or the “Company”), a technology innovator specializing in non-invasive health monitoring solutions, today announced that it has entered into an agreement with Goldeneye 1995 LLC (“Buyer”), an affiliate of fintech inv |
|
| June 6, 2025 |
EXHIBIT 10.3 FORM OF REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [], 2025, by and among Know Labs, Inc., a Nevada corporation, with headquarters located at 619 Western Avenue, Suite 610, Seattle, Washington 98104 (the “Company”), Goldeneye 1995 LLC, a Nevada limited liability company (the “Buyer”), and J.V.B. Financial Group, LLC, a Delaware limited |
|
| June 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 4, 2025 |
Certificate of Designation of the Series H Convertible Preferred Stock of Know Labs, Inc. EXHIBIT 3.1 CERTIFICATE OF DESIGNATION OF THE SERIES H CONVERTIBLE PREFERRED STOCK OF KNOW LABS, INC. The Board of Directors (the “Board”) of Know Labs, Inc., a Nevada corporation (the “Corporation”), acting pursuant to and in accordance with the provisions of Nevada Revised Statutes (“NRS”) 78.195 and 78.1955 and the Corporation’s articles of incorporation, as amended to date (the “Articles of In |
|
| June 4, 2025 |
Promissory Note Conversion Agreement between Know Labs, Inc. and J3E2A2Z LP, dated June 2, 2025 EXHIBIT 10.1 PROMISSORY NOTE CONVERSION AGREEMENT This PROMISSORY NOTE CONVERSION AGREEMENT (the “Agreement”) is made as of June 2, 2025, (the “Effective Date”) by and between Know Labs, Inc., formerly known as Visualant, Inc., a Nevada corporation (the “Company”), and J3E2A2Z LP (the “Note Holder”). The Company and Note Holder may be referred to herein individually as a “Party” and collectively a |
|
| May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File number 000-30262 KNOW LABS, INC. (Exact name of registrant a |
|
| April 25, 2025 |
EXHIBIT 107 Calculation of Filing Fee Tables FORM S-8 (Form Type) KNOW LABS, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly |
|
| April 25, 2025 |
As filed with the Securities and Exchange Commission on April 25, 2025 As filed with the Securities and Exchange Commission on April 25, 2025 Registration No. |
|
| April 25, 2025 |
2021 Know Labs, Inc. Equity Incentive Plan, as amended (to reflect Reverse Stock Split) EXHIBIT 4.1 Know Labs, Inc. 2021 EQUITY INCENTIVE PLAN SECTION 1. PURPOSE The purpose of the Know labs, Inc. 2021 Equity Incentive Plan is to attract, retain and motivate employees, officers, directors, consultants, agents, advisors and independent contractors of the Company and its Related Companies by providing them the opportunity to acquire a proprietary interest in the Company and to align th |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 28, 2025 |
Know Labs Announces NYSE Removal of Trading Suspension EXHIBIT 99.1 Know Labs Announces NYSE Removal of Trading Suspension Seattle, WA – February 28, 2025 – Know Labs, Inc. (“Know Labs” or “Company”) a leading innovator in Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology announced today that the staff of NYSE Regulation has withdrawn its delisting determination and will be lifting the trading suspension of the Company's common stock on |
|
| February 27, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 27, 2025 |
Know Labs Announces Approval to Begin Trading on the OTCQB Market EXHIBIT 99.1 Know Labs Announces Approval to Begin Trading on the OTCQB Market Seattle, WA – February 27, 2025 – Know Labs, Inc. (OTC: KNWN) a leading innovator in Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology announced today that the Company’s common shares have been approved to quote on the OTC Markets Group Inc.’s OTCQB Venture Market (the “OTCQB”) under the ticker symbol “KN |
|
| February 21, 2025 |
EXHIBIT 99.1 Know Labs Announces Cancellation of Special Meeting of Stockholders Seattle, WA – February 21, 2025 – Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today the cancellation of the Special Meeting of Stockholders previously scheduled for March |
|
| February 21, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 18, 2025 |
Certificate of Change filed with the Secretary of State of the State of Nevada on February 10, 2025. EXHIBIT 3.1 |
|
| February 18, 2025 |
Know Labs Announces Reverse Stock Split Effective February 19 2025 EXHIBIT 99.1 Know Labs Announces Reverse Stock Split Effective February 19 2025 Seattle, WA – February 18, 2025 – Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today a 1 for 40 reverse stock split of its authorized and issued and outstanding shares of c |
|
| February 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File number 000-30262 KNOW LABS, INC. (Exact name of registran |
|
| February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Num |
|
| February 3, 2025 |
EXHIBIT 99.1 Know Labs Responds to NYSE Commencement of Proceedings to Delist Know Labs Trading as “KNWN” on the OTC Market Seattle, WA – January 30, 2025 – Know Labs, Inc. (NYSE American: KNW), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today it is working on certain curative actions to regain compliance to maintain its list |
|
| January 21, 2025 |
EXHIBIT 99.1 Know Labs Launches Know Labs Technology Licensing (KTL) Company to Drive Monetization of its Patented Platform Technology Across Diverse Industries Seattle, WA – January 21, 2025 – Know Labs, Inc. (NYSE American: KNW), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), is proud to announce the formation of its new business unit, K |
|
| January 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2025 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| January 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 2, 2025 |
EXHIBIT 1.1 Know Labs, Inc. Common Stock ($0.001 par value per share) Capital on Demand™ Sales Agreement December 31, 2024 JonesTrading Institutional Services LLC 325 Hudson Street, 6th Floor New York, NY 10013 Ladies and Gentlemen: Know Labs, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows |
|
| January 2, 2025 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| January 2, 2025 |
KNOW LABS, INC. Up to $5,000,000 Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-276246 PROSPECTUS SUPPLEMENT (To prospectus dated January 11, 2024) KNOW LABS, INC. Up to $5,000,000 Common Stock We have entered into a Capital on Demand™ Sales Agreement (the “Issuance Agreement”) with JonesTrading Institutional Services LLC (the “Sales Agent”) relating to shares of our common stock, par value $0.001 per share, offered by thi |
|
| December 18, 2024 |
EXTENSION OF WARRANT AGREEMENT December 17, 2024 EXHIBIT 10.1 EXTENSION OF WARRANT AGREEMENT December 17, 2024 THIS EXTENSION OF WARRANT AGREEMENT (this “Agreement”) is made and entered into as of December 17, 2024, by and between Clayton A. Struve (the “Holder”) and Know Labs, Inc., a Nevada corporation f/k/a Visualant, Incorporated (the “Company”). RECITALS WHEREAS, the Holder owns those certain warrants to purchase shares in the Company, as s |
|
| December 18, 2024 |
Warrant Agency Agreement, December 16, 2024, between the Company and Equinity Trust Company, LLC EXHIBIT 4.2 COMMON STOCK PURCHASE WARRANT KNOW LABS, INC. Warrant Shares: Issuance Date: December 13, 2024 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received by the Company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “In |
|
| December 18, 2024 |
EXHIBIT 10.4 AMENDMENT NO. 9 TO SENIOR SECURED CONVERTIBLE REDEEMABLE DEBENTURE DATED FEBRUARY 28, 2018 This AMENDMENT NO. 9 TO SENIOR SECURED CONVERTIBLE REDEEMABLE DEBENTURE dated FEBRUARY 28, 2018 (this “Amendment”) is made and entered into as of December 17, 2024, by and between Clayton A. Struve (the “Holder”) and Know Labs, Inc., a Nevada corporation f/k/a Visualant, Incorporated (the “Compa |
|
| December 18, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 18, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 18, 2024 |
Form of Subscription Agreement EXHIBIT 10.1 FORM OF SUBSCRIPTION AGREEMENT Know Labs, Inc. 619 Western Avenue, Suite 610 Seattle, Washington 98104 Ladies and Gentlemen: The undersigned (the “Investor”) hereby confirms and agrees with you as follows: 1. This Subscription Agreement (this “Agreement”) is made as of the date set forth below between Know Labs, Inc., a Nevada corporation (the “Company”), and the Investor. 2. The Comp |
|
| December 18, 2024 |
Know Labs, Inc. Announces $300K Registered Direct Offering EXHIBIT 99.1 Know Labs, Inc. Announces $300K Registered Direct Offering SEATTLE, December 13, 2024-(BUSINESS WIRE)-Know Labs, Inc. (NYSE American: KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a registered direct offering with gross proceeds to the company expected to be approximately $300K before deducting placement agent f |
|
| December 18, 2024 |
EXHIBIT 10.2 AMENDMENT NO. 10 TO SENIOR SECURED CONVERTIBLE REDEEMABLE DEBENTURE DATED AUGUST 14, 2017 This AMENDMENT NO. 10 TO SENIOR SECURED CONVERTIBLE REDEEMABLE DEBENTURE dated AUGUST 14, 2017 (this “Amendment”) is made and entered into as of December 17, 2024, by and between Clayton A. Struve (the “Holder”) and Know Labs, Inc., a Nevada corporation f/k/a Visualant, Incorporated (the “Company |
|
| December 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 18, 2024 |
EXHIBIT 4.1 WARRANT AGENCY AGREEMENT This Warrant Agency Agreement (this “Warrant Agreement”) dated as of December 16, 2024 is made between Know Labs, Inc., a Nevada corporation (the “Company”), and Equiniti Trust Company, LLC (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Placement Agent and Advisory Services Agreement, dated December 12, 2024, by and among the Company and |
|
| December 18, 2024 |
EXHIBIT 10.1 AMENDMENT NO. 10 TO 10% CONVERTIBLE REDEEMABLE NOTE DATED SEPTEMBER 30, 2016 This AMENDMENT NO. 10 TO 10% REDEEMABLE nOTE dated SEPTEMBER 30, 2016 (this “Amendment”) is made and entered into as of December 17, 2024, by and between Clayton A. Struve (the “Holder”) and Know Labs, Inc., a Nevada corporation f/k/a Visualant, Incorporated (the “Company”). RECITALS WHEREAS, the Company is a |
|
| December 18, 2024 |
EXHIBIT 10.3 AMENDMENT NO. 10 TO SENIOR SECURED CONVERTIBLE REDEEMABLE DEBENTURE DATED DECEMBER 12, 2017 This AMENDMENT NO. 10 TO SENIOR SECURED CONVERTIBLE REDEEMABLE DEBENTURE dated DECEMBER 12, 2017 (this “Amendment”) is made and entered into as of December 17, 2024, by and between Clayton A. Struve (the “Holder”) and Know Labs, Inc., a Nevada corporation f/k/a Visualant, Incorporated (the “Com |
|
| December 16, 2024 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-276246 PROSPECTUS SUPPLEMENT (To prospectus dated January 11, 2024) 1,250,000 Units consisting of 1,250,000 Shares of Common Stock and 1,250,000 Warrants to purchase 1,250,000 Shares of Common Stock, and 1,337,500 Shares of Common Stock Underlying the Warrants Offered as part of the Units and the Warrants issued to the placement agent hereunder |
|
| December 11, 2024 |
Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance EXHIBIT 99.1 Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance SEATTLE – December 11, 2024 – Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that on December 10, 2024, it received notification (the "Acceptance Letter") from the NYSE American LLC (the "NYSE American") that the Company's previously-submitte |
|
| December 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37479 |
|
| November 14, 2024 |
Insider Trading Policy of Know Labs, Inc. dated November 2018. EXHIBIT 19 KNOW LABS, INC. INSIDER TRADING POLICY (November 2018) I. Purpose of this Policy In the course of performing your duties for Know Labs, Inc, you may from time to time receive or become aware of material nonpublic information about the company and its subsidiaries (the “Company”) or other companies that do business with the Company. This Insider Trading Policy (the “Policy”) furnishes gu |
|
| November 14, 2024 |
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. EXHIBIT 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES General As of November 14, 2024, Know Labs, Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) our common stock, par value $0.001 per share. All outstanding shares of the Company’s capital stock are fully paid and nonassessable. The following |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37479 KNOW LABS, INC. (Ex |
|
| November 14, 2024 |
Subsidiaries of the Registrant. EXHIBIT 21.1 SUBSIDIARIES As of September 30, 2024, the following was the Registrant's significant operating Subsidiaries: Name: Particle, Inc. Country of Organization: U.S. Percent Ownership by Registrant: 100.0% by Know Labs, Inc. |
|
| October 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 30, 2024 |
Certificate of Amendment to Articles of Incorporation EXHIBIT 3.1 |
|
| October 30, 2024 |
EXHIBIT 10.1 Know Labs, Inc. 2021 EQUITY INCENTIVE PLAN SECTION 1. PURPOSE The purpose of the Know labs, Inc. 2021 Equity Incentive Plan is to attract, retain and motivate employees, officers, directors, consultants, agents, advisors and independent contractors of the Company and its Related Companies by providing them the opportunity to acquire a proprietary interest in the Company and to align t |
|
| October 28, 2024 |
EXHIBIT 10.2 AMENDMENT NO. 11 TO CONVERTIBLE REDEEMABLE PROMISSORY NOTE DATED JANUARY 31, 2018 THIS AMENDMENT NO. 11 TO CONVERTIBLE REDEEMABLE PROMISSORY NOTE DATED JANUARY 31, 2018 in the principal amount of US$664,233 (this “Amendment”) is made and entered into as of October 22, 2024, by and between J3E2A2Z LP (the “Holder”), and Know Labs, Inc., a Nevada corporation f/k/a Visualant, Incorporate |
|
| October 28, 2024 |
EXHIBIT 10.1 AMENDMENT NO. 11 TO CONVERTIBLE REDEEMABLE PROMISSORY NOTE DATED JANUARY 31, 2018 THIS AMENDMENT NO. 11 TO CONVERTIBLE REDEEMABLE PROMISSORY NOTE DATED JANUARY 31, 2018 in the principal amount of US$519,833 (this “Amendment”) is made and entered into as of October 22, 2024, by and between J3E2A2Z LP (the “Holder”), and Know Labs, Inc., a Nevada corporation f/k/a Visualant, Incorporate |
|
| October 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 9, 2024 |
Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) |
|
| October 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| October 2, 2024 |
EXHIBIT 99.1 Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards A Plan for Compliance and Activities to Increase Know Labs Valuation have been Undertaken Seattle, WA, October 2, 2024 — Know Labs, Inc. (NYSE American: KNW) (the “Company” or “Know Labs”), a leading developer of non-invasive diagnostics technology, announced today that it recei |
|
| October 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| September 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 16, 2024 |
Warrant Agency Agreement, August 15, 2024, between the Company and Equinity Trust Company, LLC EXHIBIT 4.2 WARRANT AGENCY AGREEMENT This Warrant Agency Agreement (this “Warrant Agreement”) dated as of August 15, 2024 is made between Know Labs, Inc., a Nevada corporation (the “Company”), and Equiniti Trust Company, LLC (the “Warrant Agent”). WHEREAS, the Company is engaged in registered direct offering (the “Offering”) of up to 6,365,385 units (the “Units”), with each Unit being comprised of |
|
| August 16, 2024 |
Know Labs, Inc. Announces $1.655 Million Public Offering EXHIBIT 99.1 Know Labs, Inc. Announces $1.655 Million Public Offering SEATTLE – August 16, 2024 – Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced that it has entered into definitive agreements with certain investors to purchase 6,365,385 Units for an aggregate offering of $1.655 million at a public offering pr |
|
| August 16, 2024 |
EXHIBIT 4.1 COMMON STOCK PURCHASE WARRANT KNOW LABS, INC. Warrant Shares: Issuance Date: , 2024 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received by the Company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exerc |
|
| August 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 16, 2024 |
Form of Subscription Agreement EXHIBIT 10.1 FORM OF SUBSCRIPTION AGREEMENT Know Labs, Inc. 619 Western Avenue, Suite 610 Seattle, Washington 98104 Ladies and Gentlemen: The undersigned (the “Investor”) hereby confirms and agrees with you as follows: 1. This Subscription Agreement (this “Agreement”) is made as of the date set forth below between Know Labs, Inc., a Nevada corporation (the “Company”), and the Investor. 2. The Comp |
|
| August 16, 2024 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-276246 PROSPECTUS SUPPLEMENT (To prospectus dated January 11, 2024) KNOW LABS, INC. 6,365,385 Units consisting of 6,365,385 Shares of Common Stock and 6,365,385 Warrants to purchase 6,365,385 Shares of Common Stock, and 7,001,923 Shares of Common Stock Underlying the Warrants Offered as part of the Units and the Warrants issued to the Advisors |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File number 000-30262 KNOW LABS, INC. (Exact name of registrant as |
|
| August 13, 2024 |
Unit Purchase Option, dated August 9, 2024, between the Company and Sutter Securities Group, Inc. EXHIBIT 4.2 THE REGISTERED HOLDER OF THIS UNIT PURCHASE OPTION BY ITS ACCEPTANCE HEREOF, AGREES THAT THE SECURITIES EVIDENCED BY THIS UNIT PURCHASE OPTION MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS UNIT PURCHASE OPTION AGREES THAT THE SECURITIES EVIDENCED BY THIS UNIT PURCHASE OPTION WILL NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOT |
|
| August 13, 2024 |
EXHIBIT 4.1 COMMON STOCK PURCHASE WARRANT KNOW LABS, INC. Warrant Shares: Issuance Date: , 2024 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received by the Company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exerc |
|
| August 13, 2024 |
Unit Purchase Option, dated August 9, 2024, between the Company and The Benchmark Company, LLC EXHIBIT 4.3 THE REGISTERED HOLDER OF THIS UNIT PURCHASE OPTION BY ITS ACCEPTANCE HEREOF, AGREES THAT THE SECURITIES EVIDENCED BY THIS UNIT PURCHASE OPTION MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS UNIT PURCHASE OPTION AGREES THAT THE SECURITIES EVIDENCED BY THIS UNIT PURCHASE OPTION WILL NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOT |
|
| August 13, 2024 |
EXHIBIT 1.1 UNDERWRITING AGREEMENT August 7, 2024 Boustead Securities, LLC 6 Venture, Suite 265 Irvine, CA 92618 The Benchmark Company LLC 150 E. 58th Street, 17th floor New York, NY 10155 As Representatives of the several Underwriters named on Schedule 1 attached hereto Ladies and Gentlemen: The undersigned, Know Labs, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (thi |
|
| August 13, 2024 |
Warrant Agency Agreement, August 9, 2024, between the Company and Equity Trust Company, LLC EXHIBIT 4.4 WARRANT AGENCY AGREEMENT This Warrant Agency Agreement (this “Warrant Agreement”) dated as of August 9, 2024 is made between Know Labs, Inc., a Nevada corporation (the “Company”), and Equiniti Trust Company, LLC (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement, dated August 7, 2024, by and among the Company and the Representatives (as defined |
|
| August 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 13, 2024 |
Know Labs, Inc. Announces Closing of $3.445 Million Public Offering EXHIBIT 99.2 Know Labs, Inc. Announces Closing of $3.445 Million Public Offering SEATTLE – August 12, 2024 – Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostics technology, today announced the successful closing of its previously announced underwritten public offering of 13,250,000 units at a public offering price of $0.26 per unit, with each unit consisti |
|
| August 13, 2024 |
Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering EXHIBIT 99.1 Know Labs, Inc. Announces Pricing of $3.445 Million Public Offering SEATTLE – August 7, 2024 – Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment underwritten public offering of 13,250,000 units at a public offering price of $0.26 per unit, with each unit consisting o |
|
| August 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| August 9, 2024 |
Filed Pursuant to Rule 424(b)(4) Registration No. 333‑280273 PROSPECTUS KNOW LABS, INC. 13,250,000 Units consisting of 13,250,000 Shares of Common Stock and 13,250,000 Warrants to purchase 13,250,000 Shares of Common Stock 13,250,000 Shares of Common Stock Underlying the Warrants Offered hereunder This is a firm commitment public offering. Pursuant to this prospectus, we are offering 13,250,000 un |
|
| August 5, 2024 |
August 5, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| August 5, 2024 |
August 5, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| August 2, 2024 |
As filed with the Securities and Exchange Commission on August 2, 2024 As filed with the Securities and Exchange Commission on August 2, 2024 Registration No. |
|
| August 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| August 2, 2024 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) Know Labs, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title(1) Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Fees to Be Paid Equity Units, each Un |
|
| July 31, 2024 |
VIA EDGAR July 31, 2024 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| July 31, 2024 |
July 31, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| July 29, 2024 |
July 29, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| July 29, 2024 |
July 29, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| July 25, 2024 |
As filed with the Securities and Exchange Commission on July 24, 2024 As filed with the Securities and Exchange Commission on July 24, 2024 Registration No. |
|
| July 22, 2024 |
Form of Warrant included in the Units EXHIBIT 4.3 COMMON STOCK PURCHASE WARRANT KNOW LABS, INC. Warrant Shares: Issuance Date: , 2024 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received by the Company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exerc |
|
| July 22, 2024 |
As filed with the Securities and Exchange Commission on July 22, 2024 As filed with the Securities and Exchange Commission on July 22, 2024 Registration No. |
|
| July 22, 2024 |
Form of Underwriting Agreement EXHIBIT 1.1 UNDERWRITING AGREEMENT , 2024 Boustead Securities, LLC 6 Venture, Suite 265 Irvine, CA 92618 The Benchmark Company LLC 150 E. 58th Street, 17th floor New York, NY 10155 As Representatives of the several Underwriters named on Schedule 1 attached hereto Ladies and Gentlemen: The undersigned, Know Labs, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agree |
|
| July 11, 2024 |
EXHIBIT 99.1 Know Labs Publishes Clinical Results in Leading Diabetes Journal Study demonstrates accuracy for a proof-of–concept non-invasive glycemic status screening device. SEATTLE – July 11, 2024 – Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced the publication of its peer-reviewed study in Diabetes Technology & Therapeut |
|
| July 11, 2024 |
July 10, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| July 11, 2024 |
VIA EDGAR July 11, 2024 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| July 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number |
|
| July 11, 2024 |
July 11, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| July 10, 2024 |
July 10, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. |
|
| July 9, 2024 |
COMMON STOCK PURCHASE WARRANT KNOW LABS, INC. EXHIBIT 4.3 COMMON STOCK PURCHASE WARRANT KNOW LABS, INC. Warrant Shares: Issuance Date: , 2024 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received by the Company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defin |
|
| July 9, 2024 |
As filed with the Securities and Exchange Commission on July 9, 2024 As filed with the Securities and Exchange Commission on July 9, 2024 Registration No. |
|
| July 9, 2024 |
EXHIBIT 4.4 WARRANT AGENCY AGREEMENT This Warrant Agency Agreement (this “Warrant Agreement”) dated as of , 2024 is made between Know Labs, Inc., a Nevada corporation (the “Company”), and Equiniti Trust Company, LLC (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement, dated , 2024, by and among the Company and the Representatives (as defined therein), the C |
|
| July 9, 2024 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) Know Labs, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title(1) Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Fees to Be Paid Equity Units, each Un |
|
| July 2, 2024 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) Know Labs, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title(1) Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Fees to Be Paid Equity Units, each Un |
|
| July 2, 2024 | ||
| July 2, 2024 |
Form of Warrant included in the Units EXHIBIT 4.3 COMMON STOCK PURCHASE WARRANT KNOW LABS, INC. Warrant Shares: Issuance Date: , 2024 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received by the Company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defin |
|
| July 2, 2024 |
Form of Underwriting Agreement EXHIBIT 1.1 UNDERWRITING AGREEMENT July 1, 2024 Boustead Securities, LLC 6 Venture, Suite 265 Irvine, CA 92618 As Representative of the several Underwriters named on Schedule 1 attached hereto Ladies and Gentlemen: The undersigned, Know Labs, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with Boustead Securities, LLC (hereinafter referred to as “you” |
|
| July 2, 2024 |
EXHIBIT 4.2 FORM OF UNIT PURCHASE OPTION THE REGISTERED HOLDER OF THIS UNIT PURCHASE OPTION BY ITS ACCEPTANCE HEREOF, AGREES THAT THE SECURITIES EVIDENCED BY THIS UNIT PURCHASE OPTION MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS UNIT PURCHASE OPTION AGREES THAT THE SECURITIES EVIDENCED BY THIS UNIT PURCHASE OPTION WILL NOT BE SOLD, TRANSFERRE |
|
| July 2, 2024 |
EXHIBIT 4.4 WARRANT AGENCY AGREEMENT This Warrant Agency Agreement (this “Warrant Agreement”) dated as of , 2024 is made between Know Labs, Inc., a Nevada corporation (the “Company”), and Equiniti Trust Company, LLC (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement, dated , 2024, by and among the Company and the Representatives (as defined therein), the C |
|
| July 2, 2024 |
As filed with the Securities and Exchange Commission on July 1, 2024 As filed with the Securities and Exchange Commission on July 1, 2024 Registration No. |
|
| June 17, 2024 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) Know Labs, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title(1) Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Fees to Be Paid Equity Units, each Un |
|
| June 17, 2024 |
As filed with the Securities and Exchange Commission on June 17, 2024 As filed with the Securities and Exchange Commission on June 17, 2024 Registration No. |
|
| June 3, 2024 |
KNW / Know Labs, Inc. / Baszucki Todd - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1 to Schedule 13D) KNOW LABS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 499238103 (CUSIP Number) Todd Baszucki 395 Del Monte Center, #306 Monterey, CA 93940 TEL: 831-402-5699 (Name, Address and Telephone |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File number 000-30262 KNOW LABS, INC. (Exact name of registrant a |
|
| April 15, 2024 |
April 15, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| April 12, 2024 |
KNOW LABS, INC. 10,800,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-278326 PROSPECTUS KNOW LABS, INC. 10,800,000 Shares of Common Stock This prospectus relates to the resale, from time to time, by the selling stockholder identified in this prospectus under the caption “Selling Stockholder,” of up to 4,800,000 shares of Common Stock of Know Labs, Inc., a Nevada corporation (the “Company”), $0.001 par value (the |
|
| April 9, 2024 |
As filed with the Securities and Exchange Commission on April 9, 2024 As filed with the Securities and Exchange Commission on April 9, 2024 Registration No. |
|
| March 28, 2024 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) Know Labs, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward |
|
| March 28, 2024 |
As filed with the Securities and Exchange Commission on March 28, 2024 As filed with the Securities and Exchange Commission on March 28, 2024 Registration No. |
|
| March 20, 2024 |
EXHIBIT 1.1 AT THE MARKET OFFERING AGREEMENT March 20, 2024 The Benchmark Company LLC 150 E. 58th Street, 17th Floor New York, NY 10155 Ladies and Gentlemen: Know Labs Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with The Benchmark Company LLC (the “Manager”) as follows: 1. Definitions. The terms that follow, when used in this Agreement and any Terms Agreem |
|
| March 20, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| March 20, 2024 |
KNOW LABS, INC. Up to $5,000,000 Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-276246 PROSPECTUS SUPPLEMENT (To prospectus dated January 5, 2024) KNOW LABS, INC. Up to $5,000,000 Common Stock We have entered into an At the Market Offering Agreement (the “ATM Agreement”) with The Benchmark Company, LLC (the “Agent”) relating to shares of our common stock, par value $0.001 per share (the “common stock”), offered by this pro |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File |
|
| March 6, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number |
|
| March 6, 2024 |
EXHIBIT 99.1 Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study Know Labs’ first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor’s accuracy and medical application. SEATTLE – March 6, 2024 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnos |
|
| February 29, 2024 |
EXHIBIT 10.4 SECURITY AGREEMENT SECURITY AGREEMENT (this "Agreement"), dated as of February 27, 2024, by and among KNOW LABS, INC., a Nevada corporation (the "Company"), the Guarantor (as defined below) and LIND GLOBAL FUND II LP (the "Secured Party"). WHEREAS, the Company (a) and the Secured Party have entered into that certain Securities Purchase Agreement dated as of the date hereof (as amended |
|
| February 29, 2024 |
EXHIBIT 10.3 THIS WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI |
|
| February 29, 2024 |
EXHIBIT 10.5 GUARANTY GUARANTY (the "Guaranty"), dated as of February 27, 2024, by PARTICLE, INC., a Nevada corporation (the "Guarantor"), in favor of LIND GLOBAL FUND II LP (the "Lender"). WHEREAS, Know Labs, Inc., a Nevada corporation (the "Borrower"), is the holder of 100% of the equity interests of the Guarantor; and WHEREAS, (a) the Borrower and the Lender have entered into that certain Secur |
|
| February 29, 2024 |
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of February 27, 2024, by and between Know Labs, Inc., a Nevada corporation (the “Company”), and Lind Global Fund II LP, a Delaware limited partnership (the “Investor”). BACKGROUND A. The board of directors (the “Bo |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 29, 2024 |
EXHBIIT 10.2 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILAB |
|
| February 29, 2024 |
EXHIBIT 99.1 Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives SEATTLE – February 29, 2024 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has entered into a funding agreement for an investment of up to $12 million, of which it has executed a |
|
| February 27, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 27, 2024 |
EXHIBIT 99.1 Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor The KnowU incorporates the sensor intended for FDA submission. SEATTLE – February 27, 2024 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the KnowU™, its wearable non-invasive continuous glucose monitor (CGM). The Company an |
|
| February 14, 2024 |
Know Labs, Inc. Reports First Quarter FY2024 Results EXHIBIT 99.1 Know Labs, Inc. Reports First Quarter FY2024 Results SEATTLE – February 14, 2024 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the first quarter ended December 31, 2023. Financial Highlights: · In Q1 FY 2024, Know Labs reported a net loss of $3.45 million dollars, compared to a net loss |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File number 000-30262 KNOW LABS, INC. (Exact name of registran |
|
| February 14, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2024 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| January 9, 2024 |
Know Labs, Inc. 500 Union Street, Suite 810 Seattle, Washington 98101 Know Labs, Inc. 500 Union Street, Suite 810 Seattle, Washington 98101 January 9, 2024 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Margaret Sawicki Re: Know Labs, Inc. Registration Statement on Form S-3 File No. 333-276246 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), |
|
| January 5, 2024 |
As filed with the Securities and Exchange Commission on January 5, 2024 As filed with the Securities and Exchange Commission on January 5, 2024 Registration No. |
|
| December 22, 2023 |
EXHIBIT 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Know Labs Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Fo |
|
| December 22, 2023 |
EXHIBIT 4.3 INDENTURE between Know Labs, Inc. and [] TRUSTEE Dated as of [] Providing for Issuance of Debt Securities in Series Reconciliation and tie between Indenture, dated as of , and the Trust Indenture Act of 1939, as amended. Trust Indenture Act of 1939 Section Indenture Section 310(a)(1) 6.11 (a)(2) 6.11 (a)(3) TIA (a)(4) Not Applicable (a)(5) TIA (b) 6.9; 6.11; TIA 311(a) TIA (b) TIA 312( |
|
| December 22, 2023 |
As filed with the Securities and Exchange Commission on December 22, 2023 As filed with the Securities and Exchange Commission on December 22, 2023 Registration No. |
|
| December 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37479 KNOW LABS, INC. (Ex |
|
| December 19, 2023 |
EXHIBIT 21.1 SUBSIDIARIES As of September 30, 2023, the following was the Registrant's significant operating Subsidiaries: Name: Particle, Inc. Country of Organization: U.S. Percent Ownership by Registrant: 100.0% by Know Labs, Inc. |
|
| December 14, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 14, 2023 |
EXHIBIT 99.1 Know Labs Expands Medical and Scientific Advisory Board New Members Bring Extensive Clinical Diabetes Management and FDA Expertise SEATTLE – December 14, 2023 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of four new members to the Company’s Medical and Scientific Advisory Board. The new add |
|
| December 1, 2023 |
Know Labs, Inc. Compensation Recovery Policy dated November 28, 2023. Filed herewith. EXHIBIT 10.1 KNOW LABS, INC. COMPENSATION RECOVERY POLICY (adopted as of November 28, 2023) 1. Overview. In accordance with the applicable rules of The New York Stock Exchange Listed Company Manual (the “NYSE Rules”), Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10D-1 promulgated thereunder (“Rule 10D-1”), the Board of Directors (the “Board”) of Kno |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 8, 2023 |
Know Labs Expands Board of Directors Appoints Three New Directors with Deep Sector Expertise EXHIBIT 99.1 Know Labs Expands Board of Directors Appoints Three New Directors with Deep Sector Expertise SEATTLE – November 8, 2023 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of three new members to the Company’s Board of Directors. These appointments increase the number of Directors to seven. Each n |
|
| October 31, 2023 |
Know Labs Presentation, 3rd Annual Bernstein CGM Disruptors Conference EXHIBIT 99.1 |
|
| October 31, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 31, 2023 |
EXHIBIT 99.2 Know Labs Presents at Third Annual Bernstein CGM Disruptors Conference, Details Significant Progress During the Past Year SEATTLE – October 31, 2023 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, will present at the third annual Bernstein CGM Disruptors Conference on Thursday, November 2, 2023. Presenters and institutional |
|
| October 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 26, 2023 |
KNW / Know Labs Inc / Baszucki Todd - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2 to Schedule 13G) KNOW LABS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 499238103 (CUSIP Number) Todd Baszucki 395 Del Monte Center, #306 Monterey, CA 93940 TEL: 831-402-5699 (Name, Address and Telephone Nu |
|
| October 19, 2023 |
KNW / Know Labs Inc / ERICKSON RONALD P - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) 1 KNOW LABS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 499238103 (CUSIP Number) Ronald P. Erickson c/o Know Labs, Inc. 500 Union St, Suite 810, Seattle, WA 98101 206-903-1351 (Name, Address and Telephone |
|
| September 29, 2023 |
Know Labs, Inc. Announces Pricing of $7 Million Public Offering of Common Stock EXHIBIT 99.1 Know Labs, Inc. Announces Pricing of $7 Million Public Offering of Common Stock SEATTLE – Sept 27, 2023 – Know Labs, Inc. (NYSE American: KNW) (the “Company”), an emerging developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment underwritten public offering of 28,000,000 shares of its common stock at a public offering price of $0.25 per |
|
| September 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 29, 2023 |
EXHIBIT 1.1 UNDERWRITING AGREEMENT September 26, 2023 Boustead Securities, LLC 6 Venture, Suite 265 Irvine, CA 92618 The Benchmark Company LLC 150 E. 58th Street, 17th floor New York, NY 10155 As Representatives of the several Underwriters named on Schedule 1 attached hereto Ladies and Gentlemen: The undersigned, Know Labs, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement |
|
| September 29, 2023 |
EXHIBIT 4.1 THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING SEPTEMBER 26, 2023, WHICH |
|
| September 29, 2023 |
EXHIBIT 4.2 THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING SEPTEMBER 26, 2023, WHICH |
|
| September 28, 2023 |
Know Labs, Inc. 28,000,000 Shares of Common Stock Filed Pursuant to Rule 424(B)(4) Registration No. 333-274350 Prospectus Know Labs, Inc. $7,000,000 28,000,000 Shares of Common Stock This is a firm commitment public offering. Pursuant to this prospectus, we are offering 28,000,000 shares of our common stock, par value $0.001 per share. The public offering price is $0.25 per share. Our common stock is traded on the NYSE American under the symbol “ |
|
| September 26, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 25, 2023 |
As filed with the Securities and Exchange Commission on September 25, 2023 As filed with the Securities and Exchange Commission on September 25, 2023 Registration No. |
|
| September 22, 2023 |
September 22, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| September 22, 2023 |
Know Labs, Inc. 500 Union Street, Suite 810 Seattle, Washington 98101 Know Labs, Inc. 500 Union Street, Suite 810 Seattle, Washington 98101 September 22, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Conlon Danberg Re: Know Labs, Inc. Registration Statement on Form S-1 Filed September 5, 2023 File No. 333-274350 Accele |
|
| September 20, 2023 |
As filed with the Securities and Exchange Commission on September 19, 2023 As filed with the Securities and Exchange Commission on September 19, 2023 Registration No. |
|
| September 20, 2023 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) Know Labs, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price(1) Fee Rate Amount of Registration |
|
| September 20, 2023 | ||
| September 20, 2023 |
Form of Underwriting Agreement EXHIBIT 1.1 UNDERWRITING AGREEMENT September [●], 2023 Boustead Securities, LLC 6 Venture, Suite 265 Irvine, CA 92618 The Benchmark Company LLC 150 E. 58th Street, 17th floor New York, NY 10155 As Representatives of the several Underwriters named on Schedule 1 attached hereto Ladies and Gentlemen: The undersigned, Know Labs, Inc., a Nevada corporation (the “Company”), hereby confirms its agreement |
|
| September 20, 2023 |
EXHIBIT 4.2 THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING SEPTEMBER [●], 2023, WHIC |
|
| September 19, 2023 |
EXHIBIT 10.1 |
|
| September 19, 2023 |
EXHIBIT 10.3 |
|
| September 19, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 19, 2023 |
EXHIBIT 10.1 |
|
| September 19, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 001-37479 90-0273142 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 19, 2023 |
EXHIBIT 10.4 |
|
| September 19, 2023 |
EXHIBIT 10.2 |
|
| September 19, 2023 |
EXHIBIT 10.2 |
|
| September 5, 2023 |
Subsidiaries of the Registrant. EXHIBIT 21.1 SUBSIDIARIES As of September 5, 2023, the following were the Registrant's significant operating Subsidiaries: Name: Particle, Inc. Country of Organization: U.S. Percent Ownership by Registrant: 100.0% by Know Labs, Inc. |
|
| September 5, 2023 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) Know Labs, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price(1) Fee Rate Amount of Registration |
|
| September 5, 2023 |
As filed with the Securities and Exchange Commission on , 2023 As filed with the Securities and Exchange Commission on , 2023 Registration No.333 ‑ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM S‑1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Know Labs, Inc. (Exact name of registrant as specified in its charter) Nevada 3920 90‑0273142 (State or other jurisdiction of incorporation or organization) (Primary Standard In |
|
| August 18, 2023 |
Know Labs, Inc. Reports Third Quarter FY2023 Results EXHIBIT 99.1 Know Labs, Inc. Reports Third Quarter FY2023 Results SEATTLE – August 14, 2023 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter ended June 30, 2023. Financial Highlights: · Know Labs reported a net loss of $3.59 million dollars in the third quarter of 2023, compared to a |
|
| August 18, 2023 |
Know Labs Fiscal Year 2023 Third Quarter Earnings Conference Call August 14, 2023 EXHIBIT 99.2 Know Labs Fiscal Year 2023 Third Quarter Earnings Conference Call August 14, 2023 Presenters Jordyn Hujar, Chief of Staff Ron Erickson, Chairman and Chief Executive Officer Pete Conley, Senior Vice President and Chief Financial Officer Operator Greetings. Welcome to the Know Labs Fiscal Year 2023 Third Quarter Earnings Conference Call. Please note, this conference call is being record |
|
| August 18, 2023 |
Presentation dated August 14, 2023 EXHIBIT 99.3 |
|
| August 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 14, 2023 |
EXHIBIT 3.7 |
|
| August 14, 2023 |
EXHIBIT 3.1 |
|
| August 14, 2023 |
EXHIBIT 3.6 |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 14, 2023 |
EXHIBIT 3.3 |
|
| August 14, 2023 |
EXHIBIT 3.5 |
|
| August 14, 2023 |
KNOW LABS, INC. SECOND AMENDED AND RESTATED BYLAWS Effective Date: October 15, 2021 ARTICLE I EXHIBIT 3.2 KNOW LABS, INC. SECOND AMENDED AND RESTATED BYLAWS Effective Date: October 15, 2021 ARTICLE I OFFICES 1.1 Registered Office. The address of the Corporation’s registered office in the State of Nevada is 1805 N Carson Street, Suite S, Carson City, Nevada 89701. The name of the Corporation’s registered agent at such address is Pacific Registered Agents, Inc. 1.2 Other Offices. The Corpora |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File number 000-30262 KNOW LABS, INC. (Exact name of registrant as |
|
| August 14, 2023 |
EXHIBIT 3.4 |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| July 26, 2023 |
EXHIBIT 99.1 Know Labs Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose Monitor New study validates algorithm performance for its Bio-RFID™ sensor on expanded dataset SEATTLE – July 26, 2023 – Know Labs, Inc. (NYSE American: KNW) today announced results from a new study titled, “Novel data preprocessing techniques in an expanded dataset improve machine learning mod |
|
| July 26, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number |
|
| June 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 7, 2023 |
EXHIBIT 99.1 Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring The company’s Bio-RFID™ technology takes shape as a powerful, research-grade device SEATTLE – June 7, 2023 – Know Labs (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, revealed the next stage in the development of its proprietary Bio-RFID™ technolo |
|
| May 30, 2023 |
EXHIBIT 99.1 Know Labs’ Non-Invasive Glucose Monitoring Technology Shows Improved Accuracy Latest study demonstrates a machine learning model improved Bio-RFID™ sensor’s accuracy for predicting blood glucose, using the Dexcom G6® as reference device SEATTLE – May 30, 2023 –Know Labs, Inc. (NYSE American: KNW) today announced the results of a new study titled, “Algorithm Refinement in the Non-Invas |
|
| May 30, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 15, 2023 |
EXHIBIT 10.8 SEPARATION AND RELEASE AGREEMENT THIS SEPARATION AND RELEASE AGREEMENT (“Agreement”) is entered into by and between Phillip Bosua (“Employee”) and Know Labs, Inc. f/k/a Visualant, Inc. a Nevada Corporation with its principal place of business in Seattle, King County, Washington (“Employer” or “Company”) and collectively, the “Parties” on this 23rd day of January 2023 in consideration |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File number 000-30262 KNOW LABS, INC. (Exact name of registrant a |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 5, 2023 |
EXHIBIT 99.1 Know Labs Study Validates Technical Feasibility of its Novel Sensor for Non-Invasive Glucose Monitoring Study demonstrates the Bio-RFID™ sensor can deliver stable, repeatable results in predicting blood glucose concentrations using the Dexcom G6® as a reference device SEATTLE – May 5, 2023 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic |
|
| April 21, 2023 |
Exhibit 99.1 Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Proof-of-Principle Study Study strongly supports Bio-RFID technology’s application in non-invasive bio-monitoring SEATTLE – April 21, 2023 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the results of a proof-of-principle study titled, |
|
| April 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| March 22, 2023 |
EXHIBIT 99.1 Know Labs Forms New Scientific Advisory Board, Appoints Respected Researchers in Medical Innovation as First Members SEATTLE – March 22, 2023 – Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the establishment of a Scientific Advisory Board (SAB) comprised of distinguished researchers, innovators and experts in |
|
| March 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2023 KNOW LABS, INC. (Exact name of registrant as specified in its charter) Nevada 000-30262 90-0273142 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| February 22, 2023 |
KNW / Know Labs Inc / Bosua Phillip - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 KNOW LABS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 499238103 (CUSIP Number) January 23, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 21, 2023 |
KNW / Know Labs Inc / ERICKSON RONALD P - SCHEDULE 13D/A AMENDMENT NO. 6 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) 1 KNOW LABS, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 499238103 (CUSIP Number) Ronald P. Erickson c/o Know Labs, Inc. 500 Union St, Suite 810, Seattle, WA 98101 206-903-1351 (Name, Address and Telephone |
|
| February 14, 2023 |
KNWN / Know Labs Inc / Baszucki Todd - SCHEDULE 13G/A AMENDMENT NO. 1 Passive Investment SC 13G/A 1 sc13g.htm SCHEDULE 13G/A AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 KNOW LABS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 499238103 (CUSIP Number) February 14, 2023 (Date of Event which Requires Filing of this Statement) |
